Dossiers

Dossiers

We offer B2B dossiers for out-licensing with co-development, complete development, and ready-to-license options for global markets. Our portfolio includes specialized formulations, complex generics, value-added products, 505(b)(2) drug applications, and hybrid drug products—delivering innovative solutions to the pharmaceutical industry.